Common Medicines More>>
- depression
- Crohn
- GD
- AD
Hematology More>>
- Thalassemia
- Hemophilia
- 血红蛋白尿
- Leukemia
Oncology More>>
- Cachexia
- Bladder Cancer
- Pancreatic Carcinoma
- Urothelium Carcinoma
Hepatology More>>
- Cholangiocarcinoma
- Hepatitis C
- Hepatitis B
- Liver Cirrhosis
- Medication Guidance
- Medication Q&A
- Popular Drugs
- New Drugs
- Links
- FDA Approves 177Lu-PSMA-617 for Pretreated PSMA+ Metastatic Castration-Resistant Prostate Cancer
- Adjuvant CDK4/6 Inhibitors Demonstrate Success in Early-Stage HR+ Breast Cancer Development
- Sacituzumab Govitecan Significantly Improves PFS Vs Chemo in HR+ Metastatic Breast Cancer
- Frontline Poziotinib Produces Clinically Meaningful Efficacy in NSCLC Harboring HER2 Exon 20 Insertion Mutations
- Tamoxifen Plus Extended Letrozole Improves DFS in Postmenopausal Breast Cancer
- Ivosidenib/Azacitidine Granted Priority Review Designation by FDA for IDH1+ AML
- Adjuvant Pembrolizumab Improves Distant Metastasis–Free Survival in Resected Stage IIB and IIC Melanoma
- First-ever malaria vaccine recommendation now published in a position paper and in the WHO guidelines for malaria
- Risk-Adaptive Approaches Offer Safer, Effective Strategies for Early-Stage HER2+ Breast Cancer
- Employers Highlight Barriers to Biosimilar Adoption
- Biomarkers Allow for Tailoring TNBC Treatments
- These three risk factors may have the biggest impact on dementia cases
